Legend Biotech | IPO Presentation Deck | 42 slides · page 27 of 42
The chart demonstrates dose-dependent tumor regression with LCAR-T2C treatment.
Pitch deck · traction · show_traction · balanced density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 diagram 1/1 source-note 1/1 title 1/1
Components 4
line process source-note headline
Tools 2
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.